PepFinder
melanocortin agonistMelanocortin Peptides

Setmelanotide

A selective MC4R agonist. FDA-approved (Imcivree) for obesity due to POMC, PCSK1, or LEPR deficiency. First targeted therapy for genetic obesity disorders acting on the melanocortin pathway.

weight-lossappetite-suppressiongenetic-obesityFDA-approved
3D Structure
3D Structure
1117.3 Da
Molecular Weight1,117.3 Da
FormulaC49H68N18O9S2
PubChem CID11993702
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity5597048499941139m/z1117.5
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A selective MC4R agonist. FDA-approved (Imcivree) for obesity due to POMC, PCSK1, or LEPR deficiency. First targeted therapy for genetic obesity disorders acting on the melanocortin pathway.